Arcus Biosciences Inc (RCUS)

Exchange
NYSE
Symbol
RCUS
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies in the United States. The company is headquartered in Hayward, California.
Country
USA

Stock price

At close: April 7, 2025

  • Open
    6.60
  • High
    7.41
  • Low
    6.50
  • Close
    7.26
  • Volume
    1,765,190

Financial ratios

Dec 31, 2024